Table 1.
Clinical and demographic characteristics of patients diagnosed in New York.
| Unique patient number | Age at diagnosis | Sex | Residence at the time of exposure | Year of diagnosis | Pathology | Treatment | Survival (Years) |
|---|---|---|---|---|---|---|---|
| 1 | 74 | F | Ukraine | 2012 | DLBCL | Rad | 3+ |
| 2 | 76 | F | Poland | 2012 | DLBCL | Rad/Cth | 3+ |
| 3 | 85 | F | Ukraine | 2013 | DLBCL | Rad | 2+ |
| 4 | 75 | F | Ukraine | 2012 | DLBCL | Rad/Cth | 3+ |
| 5 | 63 | M | Moldova | 2011 | DLBCL | Rad/Cth | 4+ |
| 6 | 83 | F | Ukraine | 2010 | DLBCL | Cth | 3 |
| 7 | 65 | F | China | 2011 | DLBCL | Rad | 5+ |
| 8 | 60 | F | USA | 2010 | DLBCL | Rad/Cth | 6+ |
| 9a | 61 | F | USA | 2014 | DLBCL | Rad | 1 |
| 10 | 62 | M | USA | 2011 | DLBCL | Rad/Cth | 5+ |
DLBCL: diffuse large B-cell lymphoma; Rad: radiation; Cth : chemotherapy.
Patient no. 9 died within a year of diagnosis from a cause other than lymphoma.